![](/img/cover-not-exists.png)
A randomised phase I study of etrolizumab (rhuMAb 7) in moderate to severe ulcerative colitis
Rutgeerts, P. J., Fedorak, R. N., Hommes, D. W., Sturm, A., Baumgart, D. C., Bressler, B., Schreiber, S., Mansfield, J. C., Williams, M., Tang, M., Visich, J., Wei, X., Keir, M., Luca, D., Danilenko,Volume:
62
Language:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2011-301769
Date:
August, 2013
File:
PDF, 645 KB
english, 2013